Description
Abrysvo RSV Vaccine (Respiratory Syncytial Virus Vaccine) 0.5 mL Kit (1 Kit) **Refrigerated Item
The RSV Vaccine is used as a preventative measure against the Respiratory Syncytial Virus (RSV). This family of viruses is one of the leading causes of respiratory diseases and can affect infants, young children and the elderly. By vaccinating against the virus it helps to reduce the risk of infants and young children from contracting the virus. Studies show that by introducing the RSV Vaccine in contexts such as Day Care Centres, community health centers, and homes for the elderly the risk of the virus being spread is dramatically lowered. Immunization with the RSV Vaccine boosts the immune system’s effectiveness at fighting off the virus and obtaining herd immunity from the virus.
The Abrysvo RSV Vaccine (Respiratory Syncytial Virus Vaccine) 0.5 mL Kit is a medical breakthrough, which can help protect individuals from multiple illnesses, including respiratory syncytial virus (RSV) infection. It is an injectable vaccine of 0.5 mL dosage, based on a validated (inactivated) recombinant canarypox virus (ALVAC) vector and a formalin inactivated RSV virus-like particle (VLPTM-E48E) antigen. The vaccine has two components–the primary dose at four weeks and a to booster dose at eight or nine weeks–protecting vulnerable families from an array of serious wellness complications. It offers an effective immunization for infants and young children, strengthening their natural defenses against ovecome the potentially dangerous virus and other consequences, since RSVchild’s most common and troubling causes of lower respiratory flow involve in hospitalization in developing countries. Sourcepy disease.
ABRYSVO is a vaccine indicated for active immunization for the prevention of lower respiratory tract disease (LRTD) caused by respiratory syncytial virus (RSV) in individuals 60 years of age and older. Administer a single dose (approximately 0.5 mL) of ABRYSVO intramuscula
